References
- Lee SJ, Lee IK, Jeon JH. Vascular calcification-new insights into its mechanism. IJMS. 2020;21(8):1.
- Durham AL, Speer MY, Scatena M, et al. Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness. Cardiovasc Res. 2018;114(4):590–8.
- Abbasian N. Vascular calcification mechanisms: updates and renewed insight into signaling pathways involved in high Phosphate-Mediated vascular smooth muscle cell calcification. Biomedicines. 2021;9(7):804.
- Ryu J, Ahn Y, Kook H, et al. The roles of non-coding RNAs in vascular calcification and opportunities as therapeutic targets. Pharmacol Ther. 2021;218:107675.
- Jeong G, Kwon DH, Shin S, et al. Long noncoding RNAs in vascular smooth muscle cells regulate vascular calcification. Sci Rep. 2019;9(1):5848.
- Zhang X, Chen J, Meng Q, et al. The protective effects of long non-coding RNA-ANCR on arterial calcification. J Bone Miner Metab. 2020;38(4):421–431.
- Chang Z, Yan G, Zheng J, et al. The lncRNA GAS5 inhibits the osteogenic differentiation and calcification of human vascular smooth muscle cells. Calcif Tissue Int. 2020;107(1):86–95.
- Huang C, Zhan JF, Chen YX, et al. LncRNA-SNHG29 inhibits vascular smooth muscle cell calcification by downregulating miR-200b-3p to activate the α-Klotho/FGFR1/FGF23 axis. Cytokine. 2020;136:155243.
- Carrion K, Dyo J, Patel V, et al. The long non-coding HOTAIR is modulated by cyclic stretch and WNT/β-CATENIN in human aortic valve cells and is a novel repressor of calcification genes. PLOS One. 2014;9(5):e96577.
- Liu F, Yang XC, Chen ML, et al. LncRNA H19/Runx2 axis promotes VSMCs transition via MAPK pathway. Am J Transl Res. 2020;12(4):1338–1347.
- Yu C, Li L, Xie F, et al. LncRNA TUG1 sponges miR-204-5p to promote osteoblast differentiation through upregulating Runx2 in aortic valve calcification. Cardiovasc Res. 2018;114(1):168–179.
- Lin X, Zhan JK, Zhong JY, et al. lncRNA-ES3/miR-34c-5p/BMF axis is involved in regulating high-glucose-induced calcification/senescence of VSMCs. Aging. 2019;11(2):523–535.
- Xiao X, Zhou T, Guo S, et al. LncRNA MALAT1 sponges miR-204 to promote osteoblast differentiation of human aortic valve interstitial cells through up-regulating Smad4. Int J Cardiol. 2017;243:404–412.
- Alkagiet S, Tziomalos K. Vascular calcification: the role of microRNAs. Biomol Concepts. 2017;8(2):119–123.
- Zhang BQ, Li TT, Wang C, et al. LncRNA MALAT1: a potential therapeutic target in DSS-induced ulcerative colitis progression in vitro. Trop J Pharm Res. 2020;19(9):1871–1877.
- Yi J, Liu D, Xiao J. LncRNA MALAT1 sponges miR-30 to promote osteoblast differentiation of adipose-derived mesenchymal stem cells by promotion of Runx2 expression. Cell Tissue Res. 2019;376(1):113–121.
- Liu C, Zhuo H, Ye MY, et al. LncRNA MALAT1 promoted high glucose-induced pyroptosis of renal tubular epithelial cell by sponging miR-30c targeting for NLRP3. Kaohsiung J Med Sci. 2020;36(9):682–691.
- Herrmann J, Babic M, Tölle M, et al. Research models for studying vascular calcification. IJMS. 2020;21(6):2204.
- Zhang X, Hamblin MH, Yin KJ. The long noncoding RNA Malat1: its physiological and pathophysiological functions. RNA Biol. 2017;14(12):1705–1714.
- Sohrabifar N, Ghaderian SMH, Alipour Parsa S, et al. Variation in the expression level of MALAT1, MIAT and XIST lncRNAs in coronary artery disease patients with and without type 2 diabetes mellitus. Arch Physiol Biochem. 2022;128(5):1308–1315.
- Abdulle LE, Hao JL, Pant OP, et al. MALAT1 as a diagnostic and therapeutic target in diabetes-related complications: a promising long-noncoding RNA. Int J Med Sci. 2019;16(4):548–555.
- Yu CK, Xu T, Assoian RK, et al. Mining the Stiffness-Sensitive transcriptome in human vascular smooth muscle cells identifies long noncoding RNA stiffness regulators. Arterioscler Thromb Vasc Biol. 2018;38(1):164–173.
- Balderman JA, Lee HY, Mahoney CE, et al. Bone morphogenetic protein-2 decreases microRNA-30b and microRNA-30c to promote vascular smooth muscle cell calcification. J Am Heart Assoc. 2012;1(6):e003905.
- Ciceri P, Falleni M, Tosi D, et al. High-phosphate induced vascular calcification is reduced by iron citrate through inhibition of extracellular matrix osteo-chondrogenic shift in VSMCs. Int J Cardiol. 2019;297:94–103.
- Zhang L, Li G, Wang K, et al. MiR-30 family members inhibit osteoblast differentiation by suppressing Runx2 under unloading conditions in MC3T3-E1 cells. Biochem Biophys Res Commun. 2020;522(1):164–170.
- Torremadé N, Bozic M, Panizo S, et al. Vascular calcification induced by chronic kidney disease is mediated by an increase of 1α-hydroxylase expression in vascular smooth muscle cells. J Bone Miner Res. 2016;31(10):1865–1876.
- Lin ME, Chen TM, Wallingford MC, et al. Runx2 deletion in smooth muscle cells inhibits vascular osteochondrogenesis and calcification but not atherosclerotic lesion formation. Cardiovasc Res. 2016;112(2):606–616.
- Lin ME, Chen T, Leaf EM, et al. Runx2 expression in smooth muscle cells is required for arterial medial calcification in mice. Am J Pathol. 2015;185(7):1958–1969.